 Zeniquin
 View other items in the same category as Zeniquin Product UsesZeniquin tablets are indicated for the treatment of infections in dogs and cats associated with bacteria susceptible to marbofloxacin. Clinical effectiveness was confirmed in bacterial skin and soft tissue infections in dogs and cats and urinary tract infections (cystitis) in dogs associated with bacteria susceptible to marbofloxacin. Product Containsmarbofloxacin Dosage and AdministrationThe recommended dosage for oral administration to dogs and cats is 1.25 mg marbofloxacin per lb of body weight once daily, but the dosage may be safely increased to 2.5 mg/lb. For the treatment of skin and soft tissue infections, Zeniquin tablets should be given for 2-3 days beyond the cessation of clinical signs for a maximum of 30 days. For the treatment of urinary tract infections, Zeniquin tablets should be administered for at least 10 days. If no improvement is noted within 5 days, the diagnosis should be re-evaluated and a different course of therapy considered. Warnings, Side Effects and Drug InteractionsCompounds (eg, sucralfate, antacids, and multivitamins) containing divalent and trivalent cations (eg, iron, aluminum, calcium, magnesium, and zinc) may substantially interfere with the absorption of quinolones resulting in a decrease in effectiveness. Vomiting, a loss of appetite, diarrhea and lethargy have been seen with high doses of this medication. Marbofloxacin and other quinolones have been shown to cause cartilage damage in immature animals of most species tested, the dog being particularly sensitive to this side effect. Marbofloxacin is contraindicated in immature dogs during the rapid growth phase (between 2 and 8 months of age in small and medium-sized breeds, and up to 18 months of age in large and giant breeds). Quinolones should be used with caution in animals with known or suspected central nervous system (CNS) disorders as, in rare instances, convulsive seizures have occurred. The use of fluoroquinolones in cats has been reported to adversely affect the retina. Such products should be used with caution in cats. Safety in breeding or pregnant dogs and cats has not been established. Avoid contact with eyes. In case of contact, immediately flush eyes with copious amounts of water for 15 minutes. In case of dermal contact, wash skin with soap and water. Consult a physician if irritation persists following ocular or dermal exposure. Individuals with a history of hypersensitivity to quinolones should avoid this product. In humans, there is a risk of user photosensitization within a few hours after excessive exposure to quinolones. If excessive accidental exposure occurs, avoid direct sunlight. StorageStore below 30°C (86°F). ManufacturerPfizer Animal Health Federal law restricts this drug to use by or on the order of a licensed veterinarian.
|
